13F-HR filed by RTW INVESTMENTS, LP
RTW INVESTMENTS, LP filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 102 holding rows worth $5,960,261,000.
- Accession
- 0001493152-21-003922
- Filer
- CIK 1493215
- Filed
- 2021-02-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2020
A holdings report, 102 entries on the cover page, a total value of $5,960,261,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $5,960,264,000 with VALUE read as thousands by filing date, 13F file number 028-16670. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerRTW MASTER FUND, LTD.028-16671
- included managerRTW Innovation Master Fund Ltd.028-19525
- included managerRTW Venture Fund Ltd028-19571
- included managerRTW Special Purpose Fund II, LLC028-19631
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 17,060,211 | $935,582,000 | thousands by filing date | |
| IMMUNOVANT INC | 45258J102 | COM | 7,592,253 | $350,686,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 4,221,836 | $257,659,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,054,364 | $231,581,000 | thousands by filing date | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 3,544,248 | $219,495,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 1,681,645 | $218,563,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 1,712,234 | $170,402,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 7,253,857 | $159,802,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 1,790,996 | $152,109,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 4,517,570 | $139,503,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 1,672,416 | $136,252,000 | thousands by filing date | |
| ILLUMINA INC | 452327109 | COM | 361,778 | $133,858,000 | thousands by filing date | |
| CERNER CORP | 156782104 | COM | 1,701,680 | $133,548,000 | thousands by filing date | |
| MASIMO CORP COM | 574795100 | Stock | 469,416 | $125,982,000 | thousands by filing date | |
| GLOBUS MED INC CL A | 379577208 | Stock | 1,640,859 | $107,017,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 3,995,000 | $101,952,000 | thousands by filing date | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 2,463,601 | $98,987,000 | thousands by filing date | |
| AXONICS INC | 05465P101 | COM | 1,883,864 | $94,042,000 | thousands by filing date | |
| DERMTECH INC | 24984K105 | COM | 2,887,215 | $93,661,000 | thousands by filing date | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 660,933 | $93,588,000 | thousands by filing date | |
| ATHIRA PHARMA INC | 04746L104 | COM | 2,685,779 | $88,899,000 | thousands by filing date | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 2,319,138 | $87,292,000 | thousands by filing date | |
| FREQUENCY THERAPEUTICS INC | 35803L108 | COM | 2,461,486 | $86,792,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 7,227,364 | $78,345,000 | thousands by filing date | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 581,970 | $75,004,000 | thousands by filing date | |
| PULMONX CORP | 745848101 | COM | 1,129,600 | $74,839,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 3,650,069 | $73,585,000 | thousands by filing date | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 2,149,228 | $68,679,000 | thousands by filing date | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 660,982 | $63,243,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 3,422,855 | $59,968,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 1,701,781 | $55,580,000 | thousands by filing date | |
| TRANSLATE BIO INC. | 89374L104 | Common Stock | 2,978,427 | $54,892,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 804,029 | $53,773,000 | thousands by filing date | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 799,009 | $53,653,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 1,512,673 | $48,511,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 6,722,624 | $46,453,000 | thousands by filing date | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 2,515,788 | $42,794,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 2,000,000 | $41,311,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 12,864,677 | $40,910,000 | thousands by filing date | |
| OYSTER POINT PHARMA INC | 69242L106 | COMMON STOCK | 1,925,594 | $36,240,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 5,387,513 | $35,989,000 | thousands by filing date | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 1,074,166 | $35,975,000 | thousands by filing date | |
| OUTSET MEDICAL INC | 690145107 | COM | 585,074 | $33,256,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 2,165,197 | $31,850,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 500,882 | $30,809,000 | thousands by filing date | |
| CURIS INC | 231269200 | COM | 3,727,360 | $30,527,000 | thousands by filing date | |
| BERKELEY LTS INC | 084310101 | COM | 324,734 | $29,034,000 | thousands by filing date | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 4,315,102 | $28,911,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 1,256,409 | $28,722,000 | thousands by filing date | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 1,846,843 | $25,856,000 | thousands by filing date | |
| MIMEDX GROUP INC | 602496101 | COM | 2,700,320 | $24,519,000 | thousands by filing date | |
| APYX MEDICAL CORPORATION | 03837C106 | COM | 3,391,279 | $24,417,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 2,071,409 | $24,256,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 149,761 | $23,569,000 | thousands by filing date | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 5,978,355 | $21,223,000 | thousands by filing date | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 5,009,768 | $21,041,000 | thousands by filing date | |
| TELA BIO INC | 872381108 | COM | 1,383,816 | $20,813,000 | thousands by filing date | |
| PENUMBRA INC COM | 70975L107 | Stock | 118,273 | $20,698,000 | thousands by filing date | |
| ODONATE THERAPEUTICS INC | 676079106 | COM | 1,000,139 | $19,203,000 | thousands by filing date | |
| EXAGEN INC | 30068X103 | COM | 1,250,131 | $16,502,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 5,189,862 | $15,778,000 | thousands by filing date | |
| IMMUNIC INC | 4525EP101 | COM | 920,814 | $14,079,000 | thousands by filing date | |
| ACUTUS MED INC | 005111109 | COM | 451,834 | $13,017,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 282,260 | $12,803,000 | thousands by filing date | |
| GENMARK DIAGNOSTICS INC | 372309104 | COM | 762,994 | $11,140,000 | thousands by filing date | |
| CLEARSIDE BIOMEDICAL INC | 185063104 | COM | 3,958,130 | $10,845,000 | thousands by filing date | |
| APTEVO THERAPEUTICS INC | 03835L207 | COMMON | 288,236 | $10,564,000 | thousands by filing date | |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 500,000 | $10,455,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 1,527,352 | $10,004,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 31,752 | $9,338,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 2,397,378 | $9,302,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS | G4444C102 | COM | 750,000 | $8,528,000 | thousands by filing date | |
| BRAINSWAY LTD | 10501L106 | CMN | 1,103,474 | $8,320,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 500,000 | $8,290,000 | thousands by filing date | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 166,183 | $8,065,000 | thousands by filing date | |
| LIFESCI ACQUISITION II CORP | 53229E103 | COM | 650,000 | $6,936,000 | thousands by filing date | |
| BCTG ACQUISITION CORP | 05492W103 | COM | 600,000 | $6,864,000 | thousands by filing date | |
| BCLS ACQUISITION CORP | G0904B105 | CMN | 612,500 | $6,823,000 | thousands by filing date | |
| THERAPEUTICS ACQUISITION COR | 88339T103 | COM CL A | 490,000 | $6,821,000 | thousands by filing date | |
| INMODE LTD SHS | M5425M103 | Stock | 124,999 | $5,935,000 | thousands by filing date | |
| ARYA SCIENCES ACQUISITION CO | G3166W106 | COM CL A | 500,000 | $5,425,000 | thousands by filing date | |
| PERSONALIS INC | 71535D106 | COMMON STOCK | 127,501 | $4,668,000 | thousands by filing date | |
| ITAMAR MED LTD SPONSORED ADS | 465437101 | ADR | 228,609 | $4,540,000 | thousands by filing date | |
| 5 01 ACQUISITION CORP | 33836P105 | CMN | 392,000 | $3,987,000 | thousands by filing date | |
| BIOMX INC | 09090D103 | COM | 600,000 | $3,828,000 | thousands by filing date | |
| PANACEA ACQUISITION CORP | 698102209 | UNIT 99/99/9999 | 300,000 | $3,828,000 | thousands by filing date | |
| IMMATICS N.V | N44445109 | SHS | 350,000 | $3,777,000 | thousands by filing date | |
| CHARDAN HEALTHCR ACQSTN 2 CO | 15957T206 | UNIT 99/99/9999 | 350,000 | $3,707,000 | thousands by filing date | |
| TWIST BIOSCIENCE CORP | 90184D100 | COM | 18,473 | $2,610,000 | thousands by filing date | |
| BIODESIX INC | 09075X108 | COM | 125,000 | $2,520,000 | thousands by filing date | |
| PROFOUND MED CORP | 74319B502 | COM NEW | 122,098 | $2,510,000 | thousands by filing date | |
| 908 DEVICES INC COM | 65443P102 | Stock | 40,000 | $2,278,000 | thousands by filing date | |
| MARAVAI LIFESCIENCES HLDGS A | 56600D107 | COMMON STOCK | 70,000 | $1,964,000 | thousands by filing date | |
| ORASURE TECHNOLOGIES INC | 68554V108 | COM | 184,000 | $1,948,000 | thousands by filing date | |
| ELUTIA INC | 05479K106 | CL A COM | 125,000 | $1,704,000 | thousands by filing date | |
| VINCERX PHARMA INC | 92731L114 | *W EXP 12/24/202 | 500,000 | $1,650,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U102 | *W EXP 06/09/202 | 166,666 | $942,000 | thousands by filing date | |
| BURNING ROCK BIOTECH LTD | 12233L107 | SPONSORED ADS | 30,000 | $693,000 | thousands by filing date | |
| BIORA THERAPEUTICS INC | 74319F107 | COM | 100,000 | $531,000 | thousands by filing date | |
| BIOMX INC | 09090D111 | *W EXP 10/28/202 | 600,000 | $480,000 | thousands by filing date | |
| BIOATLA INC | 09077B104 | COM | 10,000 | $340,000 | thousands by filing date | |
| SEER INC | 81578P106 | COM CL A | 4,000 | $225,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-21-003922 | this filing | 2021-02-16 | acceptance time not in the bulk data set |